‘Liquid-Tumor Biopsies' and the Future of Solid Tumor Oncology
نویسندگان
چکیده
منابع مشابه
'Liquid-Tumor Biopsies' and the Future of Solid Tumor Oncology.
no) additional tissue present for laboratory-based investigation. As a result, there has been considerable and increasing effort by academic and commercial groups to develop a reliable and clinically useful ‘liquid tumor’ biopsy strategy in a number of clinical settings. Such approaches have included both the examination of single cells (‘circulating tumor cells’) as well as free DNA in the blo...
متن کاملCirculating tumor DNA: the future of personalized medicine in oncology?
Tissue biopsy has long served as the mainstay of cancer diagnosis, staging, and therapeutic decisions, with its role evolving from simple histologic examination to complex genetic analysis. Despite its utility, biopsy represents only a single time point from a single location, often proving inadequate at fully characterizing a malignancy and its evolution because nearby tissue might contain add...
متن کاملSolid Pseudopapillary Tumor of the Pancreas: a Case Report and Literature of Review
Solid pseudopapillary tumors of the pancreas (SPT) are rare tumors of the pancreas with low malignancy potential and a very good prognostic outcome after surgery. The outcome after radical resection is favourable. A case of solid-pseudopapillary tumor (SPT) of the pancreas in a 20-year-old woman is presented. The patient underwent resection of the mass in the pancreatic head and pancreaticoduod...
متن کاملExpansion Cohorts in First-in-Human Solid Tumor Oncology Trials.
In 1962, the passage of the Kefauver-Harris Amendment to the 1938 Food, Drug, and Cosmetic Act required that sponsors seeking approval of new drugs demonstrate the drug's efficacy, in addition to its safety, through a formal process that includes "adequate and well-controlled" clinical trials as the basis to support claims of effectiveness. As a result of this amendment, FDA formalized in regul...
متن کاملPatient’s perception of tumor biopsies
The Personalized Medicine approach in oncology is a direct result of an improved understanding of complex tumor biology and advances in diagnostic technologies. In recent years, there has been an increased demand for archival and fresh tumor analysis in early clinical trials to foster proof-of-concept biomarker development, to understand resistance mechanisms, and ultimately to assess biologica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology
سال: 2016
ISSN: 0030-2414,1423-0232
DOI: 10.1159/000446440